CIK 0000875045 · Large accelerated filer
BIOGEN INC.
Sign in to watch- Ticker
- BIIB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330112644
- Phone
- 6176792000
- Business address
- 225 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-12 | Gregory Ginger EVP, Human Resources | Other disposition · Restricted Stock Unit | −1,332 | 2,298 | ||
| 2021-02-12 | Gregory Ginger EVP, Human Resources | Option exercise · Restricted Stock Unit | −1,068 | 6,472 | ||
| 2021-02-12 | Gregory Ginger EVP, Human Resources | Other disposition · Restricted Stock Unit | −1,444 | 5,028 | ||
| 2021-02-12 | Galdes Alphonse EVP Pharmaceutical Oper & Tech | Shares withheld for taxes | −253 | $278.03 | $70K | 3,192.23 |
| 2021-02-12 | Galdes Alphonse EVP Pharmaceutical Oper & Tech | Option exercise | +286 | 3,478.23 | ||
| 2021-02-12 | Galdes Alphonse EVP Pharmaceutical Oper & Tech | Option exercise | +327 | 3,805.23 | ||
| 2021-02-12 | Galdes Alphonse EVP Pharmaceutical Oper & Tech | Option exercise | +960 | 4,765.23 | ||
| 2021-02-12 | Galdes Alphonse EVP Pharmaceutical Oper & Tech | Shares withheld for taxes | −84 | $278.03 | $23K | 4,681.23 |
| 2021-02-12 | Galdes Alphonse EVP Pharmaceutical Oper & Tech | Shares withheld for taxes | −96 | $278.03 | $27K | 4,585.23 |
| 2021-02-12 | Galdes Alphonse EVP Pharmaceutical Oper & Tech | Shares withheld for taxes | −282 | $278.03 | $78K | 4,303.23 |
| 2021-02-12 | Galdes Alphonse EVP Pharmaceutical Oper & Tech | Option exercise · Restricted Stock Unit | −286 | 322 | ||
| 2021-02-12 | Galdes Alphonse EVP Pharmaceutical Oper & Tech | Other disposition · Restricted Stock Unit | −322 | 0 | ||
| 2021-02-12 | Galdes Alphonse EVP Pharmaceutical Oper & Tech | Option exercise · Restricted Stock Unit | −327 | 1,235 | ||
| 2021-02-12 | Galdes Alphonse EVP Pharmaceutical Oper & Tech | Other disposition · Restricted Stock Unit | −451 | 784 | ||
| 2021-02-12 | Galdes Alphonse EVP Pharmaceutical Oper & Tech | Option exercise · Restricted Stock Unit | −960 | 5,820 | ||
| 2021-02-12 | Galdes Alphonse EVP Pharmaceutical Oper & Tech | Other disposition · Restricted Stock Unit | −1,298 | 4,522 | ||
| 2021-02-12 | ALEXANDER SUSAN H EVP Chief Legal Off & Corp Sec | Shares withheld for taxes | −1,963 | $278.03 | $546K | 39,154 |
| 2021-02-12 | ALEXANDER SUSAN H EVP Chief Legal Off & Corp Sec | Option exercise | +1,586 | 40,740 | ||
| 2021-02-12 | ALEXANDER SUSAN H EVP Chief Legal Off & Corp Sec | Option exercise | +1,402 | 42,142 | ||
| 2021-02-12 | ALEXANDER SUSAN H EVP Chief Legal Off & Corp Sec | Option exercise | +1,367 | 43,509 |
Page 39 of 45 · 886 trades